Related Experiment Video
Updated: Sep 27, 2026

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
Different consequences of EGR2 mutants on the transactivation of human Cx32 promoter
Marco Musso1, Piercesare Balestra, Franco Taroni
1Department of Neurosciences, Ophthalmology, and Genetics, University of Genoa, c/o DIMI Viale Benedetto XV, 6-16132 Genova, Italy. genetica.medica@unige.it
Abstract:
The early growth response 2 (EGR2) transcription factor plays a crucial role in peripheral nerve myelination. Mutations of this gene are associated with a wide variety of demyelinating neuropathies differing from each other in the severity of nerve injury. Although the expression of EGR2 mutants inhibits the transactivation of myelin gene promoters, the exact molecular mechanism by which these mutations cause the alteration of the myelination process is still unknown. Recently, it was reported that EGR2 is directly involved in the transcriptional regulation of Connexin 32, a myelin gene frequently mutated in peripheral neuropathies. Here we describe the differential effect of two EGR2 mutants; while mutant D355V partially induces Cx32 promoter, mutant R381H does not. Furthermore, we show that a sequence located at -216, recognized by the wild-type and the mutant D355V recombinant proteins, is relevant for promoter transactivation.
Insights
Mutations in the early growth response 2 (EGR2) gene disrupt peripheral nerve myelination. We found EGR2 mutants differentially affect myelin gene promoter activity, revealing insights into demyelinating neuropathies.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- The early growth response 2 (EGR2) transcription factor is vital for peripheral nerve myelination.
- EGR2 mutations are linked to diverse demyelinating neuropathies with varying severity.
- The precise molecular mechanisms underlying EGR2-associated myelination defects remain unclear.
Purpose of the Study:
- To investigate the differential effects of EGR2 mutants on myelin gene promoter activity.
- To elucidate the molecular mechanisms by which EGR2 mutations alter myelination.
- To identify specific DNA sequences involved in EGR2-mediated transcriptional regulation of myelin genes.
Main Methods:
- Analysis of EGR2 mutant protein interactions with the Connexin 32 (Cx32) promoter.
- Reporter gene assays to measure promoter transactivation by wild-type and mutant EGR2.
- Identification of DNA-binding sites relevant for EGR2-mediated gene regulation.
Main Results:
- EGR2 mutant D355V partially induced the Cx32 promoter, whereas mutant R381H showed no induction.
- A specific DNA sequence at the -216 position of the Cx32 promoter was recognized by wild-type and D355V EGR2.
- This -216 sequence is crucial for promoter transactivation by EGR2.
Conclusions:
- EGR2 mutants exhibit differential impacts on the transcriptional regulation of myelin genes like Cx32.
- These findings provide mechanistic insights into how EGR2 mutations lead to demyelinating neuropathies.
- The identified -216 promoter sequence is a key regulatory element for EGR2 function in myelination.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Co-activators and Co-repressors
Reporter Genes
Commonly used reporter...
TGF - β Signaling Pathway

